Targeted Contrast Agents for Molecular MRI - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Inorganics Année : 2018

Targeted Contrast Agents for Molecular MRI

Sara Lacerda

Résumé

Molecular magnetic resonance imaging (MRI) provides information non-invasively at cellular and molecular levels, for both early diagnosis and monitoring therapeutic follow-up. This imaging technique requires the development of a new class of contrast agents, which signal changes (typically becomes enhanced) when in presence of the cellular or molecular process to be evaluated. Even if molecular MRI has had a prominent role in the advances in medicine over the past two decades, the large majority of the developed probes to date are still in preclinical level, or eventually in phase I or II clinical trials. The development of novel imaging probes is an emergent active research domain. This review focuses on gadolinium-based specific-targeted contrast agents, providing rational design considerations and examples of the strategies recently reported in the literature.

Dates et versions

hal-02068580 , version 1 (15-03-2019)

Identifiants

Citer

Sara Lacerda. Targeted Contrast Agents for Molecular MRI. Inorganics, 2018, 6 (4), pp.129. ⟨10.3390/inorganics6040129⟩. ⟨hal-02068580⟩
24 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More